ArticleIranian journal of pathology2023

Evaluation of HER2 Positivity Based on Clinicopathological Findings in HER2 Borderline Tumors in Iranian Patients with Breast Cancer.

Ramesh Omranipour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.